Rise in late-stage prostate cancer raises concerns over testing
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Rise in late-stage prostate cancer raises concerns over testing
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Late-stage prostate cancer diagnoses are on the rise in Canada. According to a recent study, between 2010 and 2021, rates of prostate cancer discovered at Stage 4 increased by about 50 per cent in men aged 50 to 74. In men over the age of 75, rates were up over 65 per cent.
There is a simple blood test that can screen for early signs of prostate cancer, called a prostate specific antigen, or PSA test; however, in 2014, Canada recommended against using the PSA for widespread screening. Today, Globe health reporter Kelly Grant explains what this study found and why these guidelines are so highly contested in Canada.
Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.